Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27,712,115
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
17,730,856
-
Shares change
-
+4,024,069
-
Total reported value, excl. options
-
$619,647,150
-
Value change
-
+$143,400,869
-
Number of buys
-
54
-
Number of sells
-
-16
-
Price
-
$34.95
Significant Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) as of Q3 2017
76 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, $0.01 par value as of Q3 2017.
ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,730,856 shares
of 27,712,115 outstanding shares and own 64% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (3,688,448 shares), FMR LLC (2,192,030 shares), BVF INC/IL (1,379,134 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,218,986 shares), Novo Holdings A/S (1,190,604 shares), Cormorant Asset Management, LLC (1,000,000 shares), PERCEPTIVE ADVISORS LLC (982,269 shares), DEERFIELD MANAGEMENT CO (824,338 shares), BlackRock Inc. (682,731 shares), and CITADEL ADVISORS LLC (583,849 shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.